《盈警響號》萊爾斯丹(00738.HK)料中期盈轉虧
萊爾斯丹(00738.HK)發盈警,預期截至今年8月底止中期錄盈轉虧,對上財年同期錄純利238.8萬元人民幣(下同)。盈轉虧主因自1月下旬以來,新型冠狀病毒疫情爆發為零售市場帶來負面影響,導致集團總零售銷售大幅減少;以及因本集團自5月起將順德工廠之鞋履生產停止,產生了一次性終止僱員合同的賠償金約3,600萬元。
而截至5月底止首財季,集團自營零售業務與去年同期相比錄得總銷售下跌38.2%及同店銷售下跌32.7%。電子商貿業務與去年同期相比錄得總銷售下跌16.4%。
截至5月底,集團於中港澳三地設有414間零售店舖,按年淨減少72間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.